宜明昂科生物医药技术（上海）股份有限公司（简称“宜明昂科-B”，股票代码01541）于2026年7月3日发布2026年6月股份变动月报表，披露截至2026年6月30日的股本情况。
公司注册股本为人民币431,507,695元，包含普通股H股与非上市股份两类。其中，H股数量在本月出现购回并转为库存股份的变动：报告期初H股总数为420,477,305股，本月内通过多次购回累计回购H股1,441,800股，价格区间约为每股3.1099港元至3.7611港元。回购后，419,035,505股H股为已发行股份，1,441,800股H股被列为库存股份，H股合计总数420,477,305股保持不变。非上市股份在本月无变化，仍为11,030,390股。
报告显示，当月公司无新增发行股份、无转换可换股票据及无授出股份期权或股权激励计划变动。截至本月末，公司总股本仍为420,477,305股，股权结构保持整体稳定。公司同时确认，其H股公众持股量符合香港联合交易所有限公司的相关要求。
该公告由执行董事、联席公司秘书关梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.